Positrigo, a company based in Switzerland that develops nuclear medical devices, has introduced the Brain PET Accelerator Program in the United States. This initiative is aimed at making advanced brain PET imaging available directly within neurology practices, eliminating the need for patients and clinicians to rely on larger hospital imaging departments.
The program seeks to address obstacles that have historically limited the use of brain PET imaging, such as complexity and cost. It offers neurologists a simplified way to implement brain PET technology at their offices by combining Positrigo’s compact equipment with operational and clinical support.
Dr. Jannis Fischer, CEO and co-founder of Positrigo, said: “Brain PET imaging has long been underutilized due to its complexity, cost, and dependence on centralized facilities. With the Brain PET Accelerator Program, Positrigo is pioneering a fundamental shift in how brain PET is delivered - bringing this powerful modality directly to neurologists and their patients at the point-of-care. Our goal is to make advanced brain imaging more accessible, practical, and impactful in everyday clinical practice.”
The program targets practices dealing with neurodegenerative diseases, cognitive disorders, and other neurological conditions where functional imaging supports diagnosis and management.
Additional details about the Brain PET Accelerator Program are available on Positrigo’s website: https://brainpetaccelerator.positrigo.com/home
